Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome.
Tambralli A, Harbaugh A, NaveenKumar SK, Radyk MD, Rysenga CE, Sabb K, Hurley JM, Sule GJ, Yalavarthi S, Estes SK, Hoy C, Smith T, Sarosh C, Madison JA, Schaefer JK, Sood SL, Zuo Y, Sawalha AH, Lyssiotis CA, Knight JS.
Tambralli A, et al. Among authors: sood sl.
J Clin Invest. 2024 Jun 13:e169893. doi: 10.1172/JCI169893. Online ahead of print.
J Clin Invest. 2024.
PMID: 38869951
Free article.